{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:49:13Z","timestamp":1788922153273,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["20451"],"award-info":[{"award-number":["20451"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jpain.2025.105456","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T02:56:31Z","timestamp":1749005791000},"page":"105456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Reduction of opioid withdrawal symptoms and opioid-induced hyperalgesia by subcutaneous sumatriptan reveals central neuromodulation"],"prefix":"10.1016","volume":"33","author":[{"given":"Alessandra","family":"Pistolesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Cesaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Buonvicino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Chiarugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2025.105456_bib1","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2165\/00003495-200060060-00003","article-title":"Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy","volume":"60","author":"Tfelt-Hansen","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.jpain.2025.105456_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10194-010-0258-4","article-title":"Why pharmacokinetic differences among oral triptans have little clinical importance: a comment","volume":"12","author":"Ferrari","year":"2011","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10194-009-0170-y","article-title":"Does sumatriptan cross the blood-brain barrier in animals and man?","volume":"11","author":"Tfelt-Hansen","year":"2010","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s10194-017-0811-5","article-title":"Triptans and CGRP blockade - impact on the cranial vasculature","volume":"18","author":"Benemei","year":"2017","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib5","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.neuron.2018.01.029","article-title":"A systems neuroscience approach to migraine","volume":"97","author":"Brennan","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.jpain.2025.105456_bib6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","article-title":"Migraine and the trigeminovascular system-40 years and counting","volume":"18","author":"Ashina","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jpain.2025.105456_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10194-009-0130-6","article-title":"Migraine pain: reflections against vasodilatation","volume":"10","author":"Panconesi","year":"2009","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10194-005-0165-2","article-title":"The pathophysiology of migraine: year 2005","volume":"6","author":"Buzzi","year":"2005","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(01)01151-7","article-title":"Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain","volume":"425","author":"Johnson","year":"2001","journal-title":"Eur J Pharm"},{"key":"10.1016\/j.jpain.2025.105456_bib10","first-page":"282","article-title":"Preclinical studies on the anti-migraine drug, sumatriptan","volume":"31","author":"Humphrey","year":"1991","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jpain.2025.105456_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/exnr.1997.6749","article-title":"Comparison of more and less lipophilic serotonin (5HT1B\/1D) agonists in a model of trigeminovascular nociception in cat","volume":"150","author":"Hoskin","year":"1998","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jpain.2025.105456_bib12","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1073\/pnas.0306147101","article-title":"Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B\/1D receptor agonists","volume":"101","author":"Levy","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jpain.2025.105456_bib13","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1468-2982.1997.1708849.x","article-title":"Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B\/1D agonist zolmitriptan (311C90, Zomig)","volume":"17","author":"Proietti-Cecchini","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpain.2025.105456_bib14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/jamaneurol.2019.0755","article-title":"Association between sumatriptan treatment during a migraine attack and central 5-HT1B receptor binding","volume":"76","author":"Deen","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jpain.2025.105456_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10194-011-0309-5","article-title":"Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment","volume":"12","author":"Tfelt-Hansen","year":"2011","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/0333102419896370","article-title":"Ultra-rapid brain uptake of subcutaneous sumatriptan in the rat: implication for cluster headache treatment","volume":"40","author":"Muzzi","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpain.2025.105456_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1468-2982.1993.1306383.x","article-title":"Amplifying effect of sumatriptan on noradrenaline venoconstriction in migraine patients","volume":"13","author":"Panconesi","year":"1993","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpain.2025.105456_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12987-024-00544-6","article-title":"The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells","volume":"21","author":"Svane","year":"2024","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jpain.2025.105456_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s10194-024-01894-0","article-title":"Regional distribution of unbound eletriptan and sumatriptan in the CNS and PNS in rats: implications for a potential central action","volume":"25","author":"Svane","year":"2024","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib20","first-page":"447","article-title":"The 'in's and out's' of descending pain modulation from the rostral ventromedial medulla","volume":"47","author":"De Preter","year":"2024","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jpain.2025.105456_bib21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jpain.2010.12.007","article-title":"Descending facilitatory pathways from the rostroventromedial medulla mediate naloxone-precipitated withdrawal in morphine-dependent rats","volume":"12","author":"Vera-Portocarrero","year":"2011","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1523\/JNEUROSCI.21-01-00279.2001","article-title":"Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance","volume":"21","author":"Vanderah","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2025.105456_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainres.2015.12.039","article-title":"Reflections on:\u00a0A general role for adaptations in G-Proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function","volume":"1645","author":"Nestler","year":"2016","journal-title":"Brain Res"},{"key":"10.1016\/j.jpain.2025.105456_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02431544","article-title":"Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal","volume":"96","author":"Taylor","year":"1988","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.jpain.2025.105456_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/bip.20254","article-title":"Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure","volume":"80","author":"Ossipov","year":"2005","journal-title":"Biopolymers"},{"key":"10.1016\/j.jpain.2025.105456_bib26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.jpain.2025.105456_bib27","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s12640-021-00331-3","article-title":"Cuprizone-dependent De\/Remyelination responses and functional correlates in mouse strains adopted to model relapsing, chronic and progressive experimental autoimmune encephalomyelitis","volume":"39","author":"Buonvicino","year":"2021","journal-title":"Neurotox Res"},{"key":"10.1016\/j.jpain.2025.105456_bib28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuroscience.2018.03.022","article-title":"Effects of class II-selective histone deacetylase inhibitor on neuromuscular function and disease progression in SOD1-ALS mice","volume":"379","author":"Buonvicino","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2025.105456_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0091-3057(93)90288-5","article-title":"Aversive and antiaversive effects of morphine in the dorsal periaqueductal gray of rats submitted to the elevated plus-maze test","volume":"44","author":"Motta","year":"1993","journal-title":"Pharm Biochem Behav"},{"key":"10.1016\/j.jpain.2025.105456_bib30","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.111.183343","article-title":"Acute oxycodone induces the pro-emetic pica response in rats","volume":"339","author":"Batra","year":"2011","journal-title":"J Pharm Exp Ther"},{"key":"10.1016\/j.jpain.2025.105456_bib31","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1523\/JNEUROSCI.14-04-02301.1994","article-title":"Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C","volume":"14","author":"Mao","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2025.105456_bib32","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/j.pain.0000000000001774","article-title":"Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models","volume":"161","author":"Urru","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib33","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1097\/j.pain.0000000000001355","article-title":"Morphine effects within the rodent anterior cingulate cortex and rostral ventromedial medulla reveal separable modulation of affective and sensory qualities of acute or chronic pain","volume":"159","author":"Gomtsian","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib34","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2008.06.085","article-title":"Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan","volume":"135","author":"Vera-Portocarrero","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jpain.2025.105456_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s10194-022-01538-1","article-title":"Migraine attacks are of peripheral origin: the debate goes on","volume":"24","author":"Do","year":"2023","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s10194-020-01132-3","article-title":"Lasmiditan mechanism of action - review of a selective 5-HT(1F) agonist","volume":"21","author":"Clemow","year":"2020","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s10194-022-01394-z","article-title":"Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT(1) receptors","volume":"23","author":"Edvinsson","year":"2022","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1468-2982.1990.1005207.x","article-title":"Lack of antinociceptive activity of sumatriptan in rodents","volume":"10","author":"Skingle","year":"1990","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpain.2025.105456_bib39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.pain.2008.06.002","article-title":"Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptan","volume":"139","author":"Nikai","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1523\/JNEUROSCI.4054-04.2005","article-title":"Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance","volume":"25","author":"Xie","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2025.105456_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0028-3908(94)90067-1","article-title":"Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain","volume":"33","author":"Bruinvels","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpain.2025.105456_bib42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/bs.pmbts.2015.10.005","article-title":"Molecular changes in opioid addiction: the role of adenylyl cyclase and cAMP\/PKA system","volume":"137","author":"Chan","year":"2016","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.jpain.2025.105456_bib43","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjp.0700968","article-title":"Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system","volume":"120","author":"Haddjeri","year":"1997","journal-title":"Br J Pharm"},{"key":"10.1016\/j.jpain.2025.105456_bib44","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1523\/JNEUROSCI.5010-04.2005","article-title":"cAMP-mediated mechanisms for pain sensitization during opioid withdrawal","volume":"25","author":"Bie","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2025.105456_bib45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s10194-023-01584-3","article-title":"Descending serotonergic modulation from rostral ventromedial medulla to spinal trigeminal nucleus is involved in experimental occlusal interference-induced chronic orofacial hyperalgesia","volume":"24","author":"Mo","year":"2023","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s10194-021-01381-w","article-title":"Alterations in pain processing circuitries in episodic migraine","volume":"23","author":"Mungoven","year":"2022","journal-title":"J Headache Pain"},{"key":"10.1016\/j.jpain.2025.105456_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114057","article-title":"Parabrachial Calca neurons drive nociplasticity","volume":"43","author":"Condon","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.jpain.2025.105456_bib48","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/86001","article-title":"Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient mice","volume":"4","author":"Salmon","year":"2001","journal-title":"Nat Neurosci"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590025006832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590025006832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T18:11:00Z","timestamp":1785694260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590025006832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":48,"alternative-id":["S1526590025006832"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2025.105456","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of opioid withdrawal symptoms and opioid-induced hyperalgesia by subcutaneous sumatriptan reveals central neuromodulation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2025.105456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of United States Association for the Study of Pain, Inc","name":"copyright","label":"Copyright"}],"article-number":"105456"}}